🔗 Share this article

This year's Nobel Prize in medical science was awarded for transformative discoveries that illuminate how the body's defense network targets harmful infections while sparing the body's own cells.

Three renowned researchers—from Japan Shimon Sakaguchi and American experts Mary Brunkow and Fred Ramsdell—received this honor.

The research uncovered specialized "sentinels" within the immune system that remove rogue immune cells that could attacking the body.

The discoveries are now enabling new therapies for immune disorders and cancer.

These laureates will divide a prize fund worth 11 million SEK.

Crucial Findings

"Their research has been essential for understanding how the immune system functions and why we do not all suffer from severe self-attack conditions," stated the head of the award panel.

The team's research explain a core mystery: In what way does the immune system protect us from countless invaders while keeping our own tissues unharmed?

The immune system employs white blood cells that search for indicators of infection, including viruses and bacteria it has not met before.

These defenders employ sensors—known as recognition units—that are generated by chance in a vast number of combinations.

This gives the immune system the capacity to fight a wide array of threats, but the randomness of the process inevitably produces immune cells that may target the body.

Protectors of the Immune System

Scientists earlier knew that some of these harmful defense cells were destroyed in the thymus—the site where immune cells mature.

This year's award honors the discovery of T-reg cells—known as the immune system's "peacekeepers"—which travel through the body to disarm any defenders that attack the healthy cells.

We know that this process fails in autoimmune diseases such as type-1 diabetes, MS, and rheumatoid arthritis.

A Nobel panel added, "These discoveries have established a new field of investigation and accelerated the creation of innovative treatments, for instance for cancer and immune disorders."

Regarding malignancies, regulatory T-cells block the system from fighting the tumor, so research are aimed at reducing their numbers.

In autoimmune diseases, experiments are testing boosting T-reg cells so the body is no longer being harmed. A similar method could also be useful in reducing the chances of organ transplant rejection.

Innovative Studies

Prof Sakaguchi, of a Japanese institution, conducted tests on rodents that had their thymus extracted, leading to self-attack conditions.

The researcher demonstrated that injecting defense cells from healthy mice could stop the disease—suggesting there was a system for preventing defenders from attacking the body.

Dr. Brunkow, from the a research center in Seattle, and Fred Ramsdell, now at a biotech firm in San Francisco, were studying an inherited autoimmune disease in rodents and people that resulted in the identification of a gene critical for how regulatory T-cells function.

"The pioneering work has uncovered how the body's defenses is kept in check by T-reg cells, stopping it from accidentally attacking the body's own tissues," commented a prominent physiology expert.

"This research is a remarkable illustration of how fundamental biological study can have broad implications for public health."